Form 4 for AKBA Akebia Therapeutics, Inc.
Accepted 2023-05-25 00:00:00 ET · period of report 2023-05-24 · accession 0001562180-23-004503 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-25 | 2023-05-24 | AKBA | Dahan Michel | SVP, COO | A - Grant | $0.00 | +200.0K | 669.5K | +43% | $0 |
| D | 2023-05-25 | 2023-05-25 | AKBA | Dahan Michel | SVP, COO | S - Sale | $1.22 | -95.5K | 574.0K | -14% | -$116.5K |
| D | 2023-05-25 | 2023-05-24 | AKBA | Dahan Michel | SVP, COO | A - Grant | $0.00 | +200.0K | 200.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-24 | A | A | 200,000 | $0.00 | 669,515 | D | — | — | (F1) As previously disclosed, in May 2022, the Reporting Person was granted performance-based restricted stock units ("PSUs") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest upon the closing of a significant transaction as defined in the award agreement. On May 24, 2023, the Company entered into a License Agreement, which transaction qualified as a significant transaction and closed on May 24, 2023. As a result, all of the PSUs vested on May 24, 2023 |
| 2 | Common | Common Stock | 2023-05-25 | S | D | 95,478 | $1.22 | 574,037 | D | — | — | (F2) This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of all of the PSUs. |
| 3 | Derivative | Employee Stock Option (Right to buy) | 2023-05-24 | A | A | 200,000 | $0.00 | 200,000 | D | $0.41 · — to 2032-05-12 | 200,000 Common Stock | (F3) As previously disclosed, in May 2022, the Reporting Person was granted performance-based options (the "Options") pursuant to the Issuer's 2014 Incentive Plan, as amended. The Options vest upon the closing of a significant transaction as defined in the award agreements. On May 24, 2023, the Company entered into a License Agreement, which transaction qualified as a significant transaction and closed on May 24, 2023. As a result, all of the shares subject to the Option vested on May 24, 2023. |